Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Liabilities and Shareholders Equity: 2014-2022

Historic Liabilities and Shareholders Equity for Cellectis (CLLS) over the last 9 years, with Dec 2022 value amounting to $22.4 million.

  • Cellectis' Liabilities and Shareholders Equity fell 24.99% to $209.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $950.0 million, marking a year-over-year decrease of 28.56%. This contributed to the annual value of $22.4 million for FY2022, which is 94.13% down from last year.
  • Per Cellectis' latest filing, its Liabilities and Shareholders Equity stood at $22.4 million for FY2022, which was down 94.13% from $382.1 million recorded in FY2021.
  • In the past 5 years, Cellectis' Liabilities and Shareholders Equity registered a high of $500.8 million during FY2018, and its lowest value of $22.4 million during FY2022.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $382.1 million (2021), whereas its average is $291.3 million.
  • In the last 5 years, Cellectis' Liabilities and Shareholders Equity spiked by 50.46% in 2018 and then plummeted by 94.13% in 2022.
  • Cellectis' Liabilities and Shareholders Equity (Yearly) stood at $500.8 million in 2018, then dropped by 6.66% to $467.5 million in 2019, then rose by 0.43% to $469.5 million in 2020, then fell by 18.62% to $382.1 million in 2021, then crashed by 94.13% to $22.4 million in 2022.